S&P Futures
4,137.50 +13.00 (+0.32%) Dow Futures
32,812.00 +75.00 (+0.23%) Nasdaq Futures
13,091.75 +60.25 (+0.46%) Russell 2000 Futures
1,919.60 +5.00 (+0.26%) Crude Oil
89.96 -0.54 (-0.60%) Gold
1,792.40 -1.60 (-0.09%)
Johnson & Johnson (JNJ)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 170.20 |
| Open | 170.54 |
| Bid | 0.00 x 1100 |
| Ask | 170.70 x 800 |
| Day's Range | 169.73 - 171.12 |
| 52 Week Range | 155.72 - 186.69 |
| Volume | |
| Avg. Volume | 6,700,843 |
| Market Cap | 447.434B |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | 24.77 |
| EPS (TTM) | 6.87 |
| Earnings Date | Oct 18, 2022 |
| Forward Dividend & Yield | 4.52 (2.66%) |
| Ex-Dividend Date | Aug 22, 2022 |
| 1y Target Est | 187.84 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for JNJ
Related Research
- Johnson & JohnsonAnalyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.RatingFair ValueEconomic Moat2 days agoMorningstar
- Motley Fool
5 of the Safest Warren Buffett Stocks You Can Confidently Buy Right Now
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has, arguably, cemented himself among the investing greats. In the 57 years he's held the reins at Berkshire, he's led his company's Class A shares (BRK.A) to an aggregate return of a scorching 3,641,613%, through Dec. 31, 2021. The Oracle of Omaha's company has outperformed the broad-based S&P 500 by so much that it's share price could fall 99% tomorrow and it would still be handily outpacing the S&P 500 since 1965.
- Business Wire
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
NEW BRUNSWICK, N.J., August 09, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).
- American City Business Journals
HCA Healthcare and Johnson & Johnson to collaborate on cardiovascular, cancer and health equity initiatives
The pair of health care giants will work to improve health equity, better support nurses and enhance patient care.
